Jed Sun is currently the Head of Rare & Epilepsy at UCB in Taiwan, a position held since 2024. Their career in the pharmaceutical industry began as a sales representative at Merck after completing military service, followed by significant roles at Novartis where they advanced through various functions including market access and product management. Recognized for strong organizational skills and strategic planning, they have worked across a diverse range of therapeutic areas, contributing to drug launches and market strategies. Jed holds a Bachelor's degree in Pharmacy from National Taiwan University, completed in 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices